Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | LTA4H | P09960 | 2/20 | 0.56 |
| ▸ | PTGIR | P43119 | 3/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | MMP12 | P39900 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL482369 | 0.90 | CA1 (0.65) | CA4PTGIRCA12CA1CA2 | |
| SCHEMBL29798085 | 0.89 | MMP2 (0.56) | CA4LTA4HPTGIRMEN1KMT2A | |
| SCHEMBL1127975 | 0.88 | CA4 (0.46) | CA4LTA4HPTGIRCA12CA1 | |
| SCHEMBL8944222 | 0.88 | CA4 (0.46) | CA4LTA4HPTGIRCA12CA1 | |
| Hydrochloric Acid SCHEMBL11848856 | 0.87 | CA1 (0.61) | CA4PTGIRCA12CA1CA2 | |
| SCHEMBL8943939 | 0.87 | CA4 (0.45) | CA4LTA4HPTGIRMEN1KMT2A | |
| SCHEMBL9018822 | 0.86 | CA4 (0.59) | CA4LTA4HCA12CA1CA2 | |
| SCHEMBL8577960 | 0.85 | PTGIR (0.44) | CA4LTA4HPTGIRCA12CA1 | |
| SCHEMBL6482376 | 0.85 | ALDH1A1 (0.58) | PTGIRCA1CA2MEN1KMT2A | |
| SCHEMBL6136227 | 0.85 | MMP2 (0.52) | CA4LTA4HPTGIRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339565-A1 | METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS | INST NAT SANTE RECH MED (FR) | 2025-11-06 | — | — | US | disclosed |
| US-12032288-B2 | Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device | FUJIFILM CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| WO-2023222909-A1 | METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS | Institut National de la Santé et de la Recherche Médicale (FR) | 2023-11-23 | — | — | WO | disclosed |
| CN-116657163-A | Method for dithioating o-dihalogenated aromatic hydrocarbon | 河南大学 | 2023-08-29 | — | — | CN | disclosed |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-08-30 | — | — | US | disclosed |
| CN-111635343-B | Preparation method of aryl monosulfide compound | 武汉工程大学 | 2022-05-10 | — | — | CN | disclosed |
| WO-2021195176-A1 | PROCESSES AND AGENTS FOR GLAUCOMA | AUFBAU MEDICAL INNOVATIONS LIMITED (IE) | 2021-09-30 | — | — | WO | disclosed |
| CN-110003065-B | Method for synthesizing asymmetric sulfide by catalyzing molecular oxygen oxidation water phase with water-soluble transition metal complex | 郑州大学 | 2021-01-05 | — | — | CN | disclosed |
| CN-111635343-A | Preparation method of aryl monosulfide compound | 武汉工程大学 | 2020-09-08 | — | — | CN | disclosed |
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | U.S. DEPARTMENT OF ENERGY | 2018-12-27 | — | — | US | disclosed |
| EP-1416301-A1 | Material composition for producing optical-waveguide and method for producing optical waveguide | Toyoda Gosei Co., Ltd. (JP) | 2004-05-06 | — | — | EP | disclosed |
| EP-1294657-A2 | CATALYSIS USING PHOSPHINE OXIDE AND SULFOXIDE COMPOUNDS | E. I. du Pont de Nemours and Company (US) | 2003-03-26 | — | — | EP | disclosed |
| US-20020137974-A1 | Catalysis using phosphine oxide and sulfoxide compounds | DUPONT POLYMERS, INC. | 2002-09-26 | — | — | US | disclosed |
| WO-2002000574-A2 | CATALYSIS USING PHOSPHINE OXIDE AND SULFOXIDE COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-01-03 | — | — | WO | disclosed |
| US-6136425-A | SUITABLE FOR A PRINTING PLATE WHICH GIVES AN EXCELLENT WATER RETENTION PROPERTY AND PREVENTS STAINS FROM OCCURRING AT NON-IMAGE PORTIONS | KONICA CORPORATION (JP) | 2000-10-24 | — | — | US | disclosed |
| WO-1998039312-A1 | STABLE ARENEDIAZONIUM SALTS, A PROCESS FOR THE PREPARATION THEREOF AND THE USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1998-09-11 | — | — | WO | disclosed |
| US-4837301-A | FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| EP-0275007-A2 | Process for the preparation of highly molecular, optionally branched polyarylene sulfides | BAYER AG (DE) | 1988-07-20 | — | — | EP | disclosed |
| US-4251521-A | HYPOGLYCEMIC AGENTS | SANDOZ, INC. (US) | 1981-02-17 | — | — | US | disclosed |
| US-4120866-A | REACTING AN AROMATIC COMPOUND WITH A SULFOXIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137974-A1 | Catalysis using phosphine oxide and sulfoxide compounds | TST, GSS, ARSA | CA4 4122/4885LTA4H 2659/4885PTGIR 2327/4885 |
| US-20180370911-A1 | PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS | TST, CBS, CRY2 | CA4 688/4885LTA4H 1139/4885PTGIR 4107/4885 |
| US-20250339565-A1 | METHOD FOR SYNTHESIZING IODO- OR ASTATOARYL COMPOUNDS USING ARYLSULFONIUM SALTS | ARSA, STS, AADAC | CA4 3160/4885LTA4H 1226/4885PTGIR 3132/4885 |
| US-11427536-B2 | Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods | TST, CBS, CRY2 | CA4 688/4885LTA4H 1139/4885PTGIR 4107/4885 |
| US-12032288-B2 | Actinic ray-sensitive or radiation-sensitive resin composition, resist film, pattern forming method, and method for manufacturing electronic device | RER1, COL1A1, RAD51 | CA4 3661/4885LTA4H 812/4885PTGIR 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.